基于伊米达的离子液体和 lysosomotropic 清洁剂的抗癌活性特征:在和体外的研究
Anastasiia Gryniukova1,2, Petro Borysko2, Iryna Myziuk2
1Department of Medical and Biological Researches, V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, National Academy of Science of Ukraine, 1 Academician Kukhar Str, Kyiv, 02094, Ukraine.
Molecular diversity
|January 21, 2024
概括
新的抗癌化合物,包括基于伊米达的离子液体和 lysosomotropic 清洁剂,对神经母细胞瘤和白血病表现出强烈的活性. 这些药物向参与癌症的关键蛋白质,表明它们可能成为新的治疗替代品.
科学领域:
- 药用化学 医学化学
- 计算化学计算化学
- 分子生物学分子生物学
背景情况:
- 抗癌药物的发现正在进行中,需要针对特定癌症类型的新药.
- 神经母细胞瘤和慢性髓性白血病仍然是严重的健康挑战,需要有效的治疗方法.
研究的目的:
- 为了合成和评估基于意达的新型长链离子液体和 lysosomotropic 清洁剂的抗癌活性.
- 研究这些化合物对神经母细胞瘤和白血病细胞系的分子标和作用机制.
主要方法:
- 合成伊米达衍生物和 lysosomotropic 清洁剂.
- 在的定量结构-活动关系 (QSAR) 建模用于活动预测.
- 在体外细胞毒性测定SK-N-DZ (神经母细胞瘤) 和K-562 (白血病) 细胞系.
- 分子对接研究,热转移试验和酶抑制试验 (SIRT1,奥罗拉激酶A,JAK2).
主要成果:
- 化合物2和7在神经母细胞瘤和白血病细胞系上表现出显著的体外细胞毒性作用.
- 对接显示了化合物2和7与Sirtuin-1 (SIRT1) 的强烈结合亲和力.
- 化合物2,4,7和9抑制了SIRT1脱乙酶活性;化合物7和9对奥罗拉激酶A表现出中度活性;化合物3,4,8和9抑制了Janus激酶2 (JAK2).
结论:
- 长链伊米达衍生物和 lysosomotropic 清洁剂对神经母细胞瘤和慢性髓性白血病表现出有前途的细胞毒性活动.
- 这些化合物有效地抑制了参与瘤发生的多个分子标,包括SIRT1,Aurora kinase A和JAK2.
- 合成的化合物代表神经母细胞瘤和慢性髓性白血病的潜在新型治疗药物,需要进一步调查.
更多相关视频
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
10.1K
05:59Author Spotlight: Advancing Antimicrobial Resistance Research with Innovative Approaches and Synthetic Compounds
Published on: September 27, 2024
2.1K
相关概念视频
01:31Lysosomes
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...